Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer

NCT00898794 · clinicaltrials.gov ↗

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific
Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: bevacizumab
OTHER: coagulation study
OTHER: laboratory biomarker analysis
OTHER: platelet aggregation test

Sponsor

Kantonsspital Graubuenden